[Atrial fibrillation and thromboembolic events prevention. State of the art]. [electronic resource]
- Minerva cardioangiologica Feb 2001
- 1-13 p. digital
Publication Type: Comparative Study; Editorial; English Abstract; Review
0026-4725
Age Factors Aged Aged, 80 and over Anticoagulants--therapeutic use Aspirin--therapeutic use Atrial Fibrillation--complications Controlled Clinical Trials as Topic Electric Countershock Fibrinolytic Agents--therapeutic use Humans Middle Aged Multivariate Analysis Platelet Aggregation Inhibitors--therapeutic use Prevalence Prospective Studies Randomized Controlled Trials as Topic Rheumatic Heart Disease--complications Risk Factors Stroke--epidemiology Thromboembolism--etiology Warfarin--therapeutic use